Print ISSN:-2581-5555

Online ISSN:-2456-9542

CODEN : IIJCDU

Article History

Received : 18-08-2021

Accepted : 08-09-2021



Article Metrics




Downlaod Files

   


Article Access statistics

Viewed: 825

PDF Downloaded: 415


Alzheimer’s disease: Causes, treatment & basic science review


Full Text PDF


Review Article

Author Details : Shivani Sharma*

Volume : 6, Issue : 3, Year : 2021

Article Page : 108-116

https://doi.org/10.18231/j.ijcaap.2021.020



Suggest article by email

Get Permission

Abstract

Alzheimer’s disease is that the most common cause of dementia in older, individuals and a major public health concern. The goal of this critical evaluation is to provide a short overview of Alzheimer’s disease. The study concentrates on the biochemical aspects of AD and MCI. It is the fourth most common cause of mortality in the United States, and it is spreading to other nations. With Alzheimer's disease, the total size of the brain decreases as the tissue loses nerve cells and connections. The loss of brain cells that occurs as a result of insanity cannot be stopped or reversed. The set up's aims include measurements for gift interventions in addition to an aim to improve research on interference and therapy. Although there are no disease-modifying medications available for Alzheimer's disease, certain options may help to reduce symptoms and enhance quality of life, therefore assisting patients to some extent. In addition, the paper discusses current attempts to create innovative treatments and improvements in the use of biomarkers for diagnosing SD.
 

Keywords: Alzheimer's disease, Dementia, Pathology, Causation, Neurodegeneration, Therapy, and



How to cite : Sharma S, Alzheimer’s disease: Causes, treatment & basic science review. IP Int J Compr Adv Pharmacol 2021;6(3):108-116


This is an Open Access (OA) journal, and articles are distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.